Ansgar Santel

Ansgar Santel has a diverse work experience in the field of biotechnology and pharmaceuticals. Their most recent position is as the Head of Translational Research & Alliance Management at Pantherna Therapeutics GmbH, where they started in November 2021. Prior to that, they worked at Ascenion GmbH as a Technology Development Manager from November 2017 to October 2021.

Before joining Ascenion, Ansgar worked as a Scientific Advisor & Writer for companies such as IPPMed GmbH and Vicomicx B.V. from January 2016 to October 2017. Ansgar also had a brief stint as a Visiting Scientist at the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in November and December 2015.

Ansgar has a long-standing association with Silence Therapeutics, where they held the position of Senior Scientist of Translational & Clinical Research from January 2005 to December 2015. Ansgar previously worked as a Scientist at Atugen AG (now Silence Therapeutics) from March 2002 to December 2004.

Ansgar's early career includes a role as a Postdoctoral Fellow at Stanford University School of Medicine from July 1998 to February 2002.

Overall, Ansgar Santel has acquired expertise in translational research, technology development, scientific advising, and clinical research throughout their career.

Ansgar Santel obtained their degree in Biology, specifically Dr. rer. nat., from The Philipp University of Marburg during the period from 1990 to 1998.